Research Papers:

A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer

Weiming Li, Huan Jia, Jichang Wang, Hao Guan, Yan Li, Dan Zhang, Yanan Tang, Thomas D. Wang and Shaoying Lu _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:30063-30076. https://doi.org/10.18632/oncotarget.16275

Metrics: PDF 1495 views  |   HTML 1856 views  |   ?  


Weiming Li1,*, Huan Jia2,*, Jichang Wang1, Hao Guan1, Yan Li1, Dan Zhang3, Yanan Tang1, Thomas D. Wang4, Shaoying Lu1

1Department of Vascular Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, 710061, P.R.China

2Department of General Surgery, The First Affiliated Hospital of Xi’an Medical University, Xi’an, Shaanxi Province, 710077, P.R.China

3Department of Gastroenterology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, 710061, P.R.China

4Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA

*Co-first authors, These authors contributed equally to this work

Correspondence to:

Shaoying Lu, email: [email protected]

Keywords: RP-1, CD44, gastric cancer, diagnosis, prognosis

Received: September 22, 2016     Accepted: March 09, 2017     Published: March 16, 2017


Early diagnosis and evaluation of prognosis are both crucial for preventing poor prognosis of patients with gastric cancer (GC), a leading cause of cancer-related deaths worldwide. Cluster of differentiation 44 (CD44), an indicator of cancer stem cells, can be specifically targeted by molecular probes and detected in tissues of GC in a large quantity. In current study we found that RP-1, a specific peptide binding to CD44 protein, exhibited the potentials of specific binding to CD44 high-expressing cancer cells both in vitro and in vivo, and the capacity of predicting prognosis of human GC in a microarray assay. Results showed that RP-1 was characterized by high affinity, sensitivity and specificity, and low toxicity, suggesting RP-1 could be an ideal bio-probe for accessory diagnosis of GC. Further immunohistochemical studies and statistical analysis of tissue microarray of human GC demonstrated similar sensitivity and specificity of RP-1 with the monoclonal anti-CD44 antibody in the diagnosis of GC, and even proved that positive RP-1 could be an independent risk factor. Therefore, this study suggests RP-1 has the potentials of binding to CD44 protein expressed on the membrane of GC cells, and demonstrates the feasibility and reliability of its further application in molecular diagnosis and prognostic prediction of GC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16275